Promising Therapeutic Strategies for Colorectal Cancer Treatment Based on Nanomaterials

Colorectal cancer (CRC) is a global health problem responsible for 10% of all cancer incidences and 9.4% of all cancer deaths worldwide. The number of new cases increases per annum, whereas the lack of effective therapies highlights the need for novel therapeutic approaches. Conventional treatment m...

Full description

Bibliographic Details
Main Authors: Natalia Krasteva, Milena Georgieva
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/14/6/1213
_version_ 1797483346639454208
author Natalia Krasteva
Milena Georgieva
author_facet Natalia Krasteva
Milena Georgieva
author_sort Natalia Krasteva
collection DOAJ
description Colorectal cancer (CRC) is a global health problem responsible for 10% of all cancer incidences and 9.4% of all cancer deaths worldwide. The number of new cases increases per annum, whereas the lack of effective therapies highlights the need for novel therapeutic approaches. Conventional treatment methods, such as surgery, chemotherapy and radiotherapy, are widely applied in oncology practice. Their therapeutic success is little, and therefore, the search for novel technologies is ongoing. Many efforts have focused recently on the development of safe and efficient cancer nanomedicines. Nanoparticles are among them. They are uniquewith their properties on a nanoscale and hold the potential to exploit intrinsic metabolic differences between cancer and healthy cells. This feature allows them to induce high levels of toxicity in cancer cells with little damage to the surrounding healthy tissues. Graphene oxide is a promising 2D material found to play an important role in cancer treatments through several strategies: direct killing and chemosensitization, drug and gene delivery, and phototherapy. Several new treatment approaches based on nanoparticles, particularly graphene oxide, are currently under research in clinical trials, and some have already been approved. Here, we provide an update on the recent advances in nanomaterials-based CRC-targeted therapy, with special attention to graphene oxide nanomaterials. We summarise the epidemiology, carcinogenesis, stages of the CRCs, and current nanomaterials-based therapeutic approaches for its treatment.
first_indexed 2024-03-09T22:45:43Z
format Article
id doaj.art-a8f99d8d41a5496a9a07c999fb169896
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-09T22:45:43Z
publishDate 2022-06-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-a8f99d8d41a5496a9a07c999fb1698962023-11-23T18:30:06ZengMDPI AGPharmaceutics1999-49232022-06-01146121310.3390/pharmaceutics14061213Promising Therapeutic Strategies for Colorectal Cancer Treatment Based on NanomaterialsNatalia Krasteva0Milena Georgieva1Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, “Acad. Georgi Bonchev” Str., bl. 21, 1113 Sofia, BulgariaInstitute of Molecular Biology “Acad. R. Tsanev”, Bulgarian Academy of Sciences, “Acad. Georgi Bonchev” Str., bl. 21, 1113 Sofia, BulgariaColorectal cancer (CRC) is a global health problem responsible for 10% of all cancer incidences and 9.4% of all cancer deaths worldwide. The number of new cases increases per annum, whereas the lack of effective therapies highlights the need for novel therapeutic approaches. Conventional treatment methods, such as surgery, chemotherapy and radiotherapy, are widely applied in oncology practice. Their therapeutic success is little, and therefore, the search for novel technologies is ongoing. Many efforts have focused recently on the development of safe and efficient cancer nanomedicines. Nanoparticles are among them. They are uniquewith their properties on a nanoscale and hold the potential to exploit intrinsic metabolic differences between cancer and healthy cells. This feature allows them to induce high levels of toxicity in cancer cells with little damage to the surrounding healthy tissues. Graphene oxide is a promising 2D material found to play an important role in cancer treatments through several strategies: direct killing and chemosensitization, drug and gene delivery, and phototherapy. Several new treatment approaches based on nanoparticles, particularly graphene oxide, are currently under research in clinical trials, and some have already been approved. Here, we provide an update on the recent advances in nanomaterials-based CRC-targeted therapy, with special attention to graphene oxide nanomaterials. We summarise the epidemiology, carcinogenesis, stages of the CRCs, and current nanomaterials-based therapeutic approaches for its treatment.https://www.mdpi.com/1999-4923/14/6/1213colorectal cancer (CRC)nanomaterialsnanocarriersnanoparticlescancer therapytargeted therapy
spellingShingle Natalia Krasteva
Milena Georgieva
Promising Therapeutic Strategies for Colorectal Cancer Treatment Based on Nanomaterials
Pharmaceutics
colorectal cancer (CRC)
nanomaterials
nanocarriers
nanoparticles
cancer therapy
targeted therapy
title Promising Therapeutic Strategies for Colorectal Cancer Treatment Based on Nanomaterials
title_full Promising Therapeutic Strategies for Colorectal Cancer Treatment Based on Nanomaterials
title_fullStr Promising Therapeutic Strategies for Colorectal Cancer Treatment Based on Nanomaterials
title_full_unstemmed Promising Therapeutic Strategies for Colorectal Cancer Treatment Based on Nanomaterials
title_short Promising Therapeutic Strategies for Colorectal Cancer Treatment Based on Nanomaterials
title_sort promising therapeutic strategies for colorectal cancer treatment based on nanomaterials
topic colorectal cancer (CRC)
nanomaterials
nanocarriers
nanoparticles
cancer therapy
targeted therapy
url https://www.mdpi.com/1999-4923/14/6/1213
work_keys_str_mv AT nataliakrasteva promisingtherapeuticstrategiesforcolorectalcancertreatmentbasedonnanomaterials
AT milenageorgieva promisingtherapeuticstrategiesforcolorectalcancertreatmentbasedonnanomaterials